Liquid biopsy with ctDNA to detect minimal residual disease after MPNST resection in neurofibromatosis patients

syn58577585

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.54464/JHU-NTAP.1274594.pc.gr.189859
studyName: Liquid biopsy with ctDNA to detect minimal residual disease after MPNST resection in neurofibromatosis patients
dataStatus: Data Pending
initiative: Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence
studyLeads: Jordina Rincon-Torroella
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: Johns Hopkins University
fundingAgency: NTAP
manifestation: MPNST
studyFileviewId: syn58577591
syn58577586
syn58577587
syn58577591
syn58577588

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Liquid biopsy with ctDNA to detect minimal residual disease after MPNST resection in neurofibromatosis patients

syn58577585

Drop files to upload

Liquid biopsy with ctDNA to detect minimal residual disease after MPNST resection in neurofibromatosis patients page is loading…